Verve Therapeutics

$27.17 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Verve Therapeutics

Verve Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops therapies that safely edit adult human genome to permanently reduce a person's risk of coronary artery disease. Verve Therapeutics serves customers worldwide.

Stock Analysis

last close $26.67
1-mo return 66.4%
3-mo return 88.2%
avg daily vol. 1.51M
52-week high 78
52-week low 10.7
market cap. $1.5B
forward pe -
annual div. -
roe -107.6%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 69.2%
baraka

Subscribe now for daily local and international financial news

Subscribe